Semin Reprod Med 2002; 20(4): 317-326
DOI: 10.1055/s-2002-36706
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Regulation of Gonadotropin Secretion: Implications for Polycystic Ovary Syndrome

Christopher R. McCartney, Christine A. Eagleson, John C. Marshall
  • Center for Research in Reproduction, Division of Endocrinology, Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
21 January 2003 (online)

ABSTRACT

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism and chronic anovulation. Although the etiology of PCOS is unknown, perturbations of gonadotropin secretion are one of the hallmarks of this disorder. In normal menstrual physiology, the monotropic rise of plasma follicle-stimulating hormone (FSH) during the luteal-follicular transition is critical for follicular development and subsequent ovulation. One of the mechanisms by which FSH is differentially synthesized involves the luteal slowing of gonadotropin-releasing hormone (GnRH) pulse frequency by ovarian steroids. In PCOS, plasma leutinizing hormone (LH) is commonly increased, FSH is typically in the lower follicular range, and LH (and by inference GnRH) pulse frequency is persistently rapid at approximately one LH pulse per hour. The etiology of the neuroendocrine abnormalities in PCOS remain unclear; however, recent studies have revealed decreased sensitivity of the GnRH pulse generator to inhibition by ovarian steroids, particularly progesterone. This abnormality is reversed by the androgen receptor antagonist flutamide, suggesting that elevated androgen levels may alter the sensitivity of the hypothalamic GnRH pulse generator to steroid inhibition and lead to enhanced LH secretion. As such, women with PCOS require higher levels of progesterone to slow the frequency of GnRH pulse secretion, resulting in inadequate FSH synthesis and persistent LH stimulation of ovarian androgens. The decreased sensitivity of the GnRH pulse generator may help to explain the genesis of PCOS during puberty. In normal early puberty, sleep-entrained increases in LH stimulate ovarian steroids, which subsequently suppress LH frequency and amplitude during the subsequent day. In hyperandrogenemic girls destined to develop PCOS, this nocturnal increase in ovarian steroids may not be adequate to suppress the GnRH pulse generator, leading to a persistently rapid LH pulse frequency, impaired FSH production, and inadequate follicular development.

REFERENCES

  • 1 Dunaif A. Insulin resistance and polycystic ovary syndrome: mechanisms and implications for pathogenesis.  Endocr Rev . 1997;  18 774-800
  • 2 Franks S. Polycystic ovary syndrome.  N Engl J Med . 1995;  333 853-861
  • 3 Taylor A E. Polycystic ovary syndrome.  Endocrinol Metab Clin North Am . 1998;  27 877-902
  • 4 Marshall J C, Eagleson C A. Neuroendocrine aspects of polycystic ovary syndrome.  Endocrinol Metab Clin North Am . 1999;  28 295-324
  • 5 Ehrmann D A, Barnes R B, Rosenfield R L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.  Endocr Rev . 1995;  16 322-353
  • 6 Steingold K, De Ziegler D, Cedars M. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.  J Clin Endocrinol Metab . 1987;  65 773-778
  • 7 Marshall J C. Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.  J Endocrinol Invest . 1998;  21 618-622
  • 8 Hall J E. Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis.  Endocrinol Metab Clin North Am . 1993;  22 75-92
  • 9 Marshall J C, Case G D, Valk T W, Corley K P, Sauder S E, Kelch R P. Selective inhibition of FSH secretion by estradiol: a mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone.  J Clin Invest . 1983;  71 248-258
  • 10 Hayes F J, Hall J E, Boepple P A, Crowley W F. Differential control of gonadotropin secretion in the human: endocrine role of inhibin.  J Clin Endocrinol Metab . 1998;  83 1835-1841
  • 11 Muttukrishna S, Fowler P A, George L, Groome N P, Knight P G. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.  J Clin Endocrinol Metab . 1996;  81 3328-3334
  • 12 Wildt L, Hausler A, Marshall G. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey.  Endocrinol . 1981;  109 376-385
  • 13 Clarke I J, Cummins J T, Findlay J K, Burman K J, Doughton B W. Effects on plasma luteinizing hormone and follicle-stimulating hormone of varying the frequency and amplitude of gonadotropin-releasing hormone pulses in ovariectomized ewes with hypothalamo-pituitary disconnection.  Neuroendocrinol . 1984;  39 214-221
  • 14 Haisenleder D J, Dalkin A C, Marshall J C. Regulation of gonadotropin gene expression. In: Knobil E, Neill J, eds. The Physiology of Reproduction 2nd ed. New York: Raven Press 1994: 1793
  • 15 Dalkin A C, Haisenleder D J, Gilrain J T, Aylor K, Yasin M, Marshall J C. Gonadotropin-releasing hormone regulation of gonadotropin subunit gene expression in female rats: actions on follicle-stimulating hormone beta messenger ribonucleic acid (mRNA) involve differential expression of pituitary activin (beta-B) and follistatin mRNAs.  Endocrinology . 1999;  140 903-908
  • 16 Kirk S E, Dalkin A C, Yasin M, Haisenleder D J, Marshall J C. Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function.  Endocrinology . 1994;  135 876-880
  • 17 Reame N, Sauder S E, Kelch R P, Marshall J C. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.  J Clin Endocrinol Metab . 1984;  59 328-337
  • 18 Filicori M, Santoro N, Merriam G R, Crowley W F. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.  J Clin Endocrinol Metab . 1986;  62 1136-1144
  • 19 Backstrom C T, McNeilly A S, Leask R M, Baird D T. Pulsatile secretion of LH, FSH, prolactin, estradiol, and progesterone during the human menstrual cycle.  Clin Endocrinol (Oxf) . 1982;  7 29-42
  • 20 Filicori M, Butler J P, Crowley W F. Neuroendocrine regulation of the corpus luteum in the human.  J Clin Invest . 1984;  73 1638-1647
  • 21 Rossmanith W G, Liu C H, Laughlin G A, Mortola J F, Suh B Y, Yen S S. Relative changes in LH pulsatility during the menstrual cycle: using data from hypogonadal women as a reference point.  Clin Endocrinol (Oxf) . 1990;  32 647-660
  • 22 Marshall J C, Dalkin A C, Haisenleder D J, Paul S J, Ortolano G A, Kelch R P. Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles.  Recent Prog Horm Res . 1991;  47 155-189
  • 23 Sollenberger M J, Carlsen E C, Johnson M L, Veldhuis J D, Evans W S. Specific physiological regulation of LH secretory events throughout the human menstrual cycle: new insights into the pulsatile mode of gonadotropin release.  J Neuroendo . 1990;  2 845-852
  • 24 Soules M R, Steiner R A, Clifton D K, Cohen N L, Aksel S, Bremner W J. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women.  J Clin Endocrinol Metab . 1984;  58 378-383
  • 25 Goodman R L, Bittman E L, Foster D L, Karsch F J. The endocrine basis of the synergistic suppression of luteinizing hormone by estradiol and progesterone.  Endocrinology . 1981;  109 1414-1417
  • 26 Nippoldt T B, Reame N E, Kelch R P, Marshall J C. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.  J Clin Endocrinol Metab . 1989;  69 67-76
  • 27 MacLusky N J, McEwen B S. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others.  Nature . 1978;  274 276-278
  • 28 Romano G J, Krust A, Pfaff D W. Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: an in situ hybridization study [erratum appears in Mol Endocrinol 1989;3:1860].  Mol Endocrinol . 1989;  3 1295-1300
  • 29 Wehrenberg W B, Wardlaw S L, Frantz A, Ferin M. β-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle.  Endocrinol . 1982;  111 879-881
  • 30 Gindoff P R, Jewelewicz R, Hembree W, Wardlaw S, Ferin M. Sustained effects of opioid antagonism during the normal human luteal phase.  J Clin Endocrinol Metab . 1988;  66 1000-1004
  • 31 Casper R F, Alapin-Rubillovitz S. Progestins increase endogenous opioid peptide activity in postmenopausal women.  J Clin Endocrinol Metab . 1985;  60 34-36
  • 32 Wardlaw S L, Wehrenberg W B, Ferin M, Antunes J L, Frantz A G. Effect of sex steroids on β-endorphin in hypophyseal portal blood.  J Clin Endocrinol Metab . 1982;  55 877-881
  • 33 Welt C K, Martin K A, Taylor A E. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.  J Clin Endocrinol Metab . 1997;  82 2645-2652
  • 34 McCartney C R, Gingrich M B, Hu Y, Evans W S, Marshall J C. Hypothalmic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone.  J Clin Endocrinol Metab . 2002;  87 2194-2200
  • 35 Conway G S, Honour J W, Jacobs H S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine, and ultrasound features in 556 patients.  Clin Endocrinol (Oxf) . 1989;  30 459-470
  • 36 Franks S. Polycystic ovary syndrome: a changing perspective.  Clin Endocrinol (Oxf) . 1989;  31 87-120
  • 37 Rebar R, Judd H L, Yen S SC. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.  J Clin Invest . 1976;  57 1320-1329
  • 38 Taylor A E, McCourt B, Martin K A. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.  J Clin Endocrinol Metab . 1997;  82 2248-2256
  • 39 Yen S SC, Lasley B L, Wang C F. The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observation of the biological action of somatostatin.  Rec Prog Hormone Res . 1975;  31 361-363
  • 40 Waldstreicher J, Santoro N F, Hall J E. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovary syndrome.  J Clin Endocrinol Metab . 1988;  66 165-172
  • 41 Buvat J, Buvat-Herbaut M, Marcolin G. A double-blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovarian syndrome.  J Clin Endocrinol Metab . 1986;  63 119-124
  • 42 Murdoch A P, McClean K G, Watson M J. Treatment of hirsutism in polycystic ovary syndrome with bromocriptine.  Br J Obstet Gynecol . 1987;  94 358-365
  • 43 Barnes R B, Lobo R A. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.  J Clin Endocrinol Metab . 1985;  61 779-782
  • 44 Cumming D C, Reid R L, Quigley M E. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome.  Clin Endocrinol (Oxf) . 1984;  20 643-648
  • 45 Berga S L, Yen S SC. Opioidergic regulation of LH pulsatility in women with PCOS.  Clin Endocrinol (Oxf) . 1989;  30 177-184
  • 46 Lobo R A, Granger L R, Wellington L P. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome.  Am J Obstet Gynecol . 1983;  145 496-503
  • 47 Paradisi R, Venturoli S, Capelli M. Effects of alpha-adrenergic blockade on pulsatile LH, FSH and prolactin secretion in polycystic ovary syndrome.  J Clin Endocrinol Metab . 1987;  65 841-846
  • 48 Rosen G F, Lobo R A. Further evidence against dopamine deficiency as a cause of inappropriate gonadotropin secretion in patients with polycystic ovary syndrome.  J Clin Endocrinol Metab . 1987;  65 891-895
  • 49 Yen S SC, Chaney C, Judd H L. Functional aberrations of the hypothalamic-pituitary system in PCOS: a consideration of pathogenesis. In: James VHT, ed. The Endocrine Function of the Human Ovary New York: Academic Press 1976: 273
  • 50 Chang R J, Mandel F P, Lu J K, Judd H L. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease.  J Clin Endocrinol Metab . 1982;  54 490-494
  • 51 Morales A J, Laughlin G A, Butzow T. Insulin, somatotrophic, and luteinizing hormone axes in non-obese and obese women with polycystic ovary syndrome: common and distinct features.  J Clin Endocrinol Metab . 1996;  81 2854-2864
  • 52 Barbieri R L, Markis A, Randall R W, Daniels G, Kistner R W, Ryan K J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.  J Clin Endocrinol Metab . 1986;  62 904-910
  • 53 Nestler J E, Jakubowicz D J, de Vargas F A. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.  J Clin Endocrinol Metab . 1998;  83 2001-2005
  • 54 Poretsky L, Piper B. Insulin resistance, hypersecretion of LH and a dual defect hypothesis for the pathogenesis of PCOS.  Obstet Gynecol . 1994;  84 613-621
  • 55 Nestler J E, Jacubowicz D J. Decreases in ovarian cytochrome P450 c17 activity and serum free testosterone after reduction of insulin secretion in PCOS.  N Engl J Med . 1996;  335 617-623
  • 56 Dunaif A, Scott D, Finegood D. The insulin sensitizing agent Troglitazone improves metabolic and reproductive abnormalities in PCOS.  J Clin Endocrinol Metab . 1996;  81 3299-3306
  • 57 Acbay O, Gundogdu S. Can metformin reduce insulin resistance in PCOS.  Fertil Steril . 1996;  65 946-949
  • 58 Melrose P, Gross L. Steroids effect the secretory modalities of GnRH release.  Endocrinology . 1987;  121 190-199
  • 59 Barnes R B, Rosenfield R L, Ehrmann D A. Ovarian hyperandrogenism as a result of congenital adrenal viralizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.  J Clin Endocrinol Metab . 1994;  79 1328-1333
  • 60 Dunaif A. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?.  J Clin Endocrinol Metab . 1986;  63 215-221
  • 61 Serafini P, Silva P D, Paulson R J. Acute modulation of hypothalamic-pituitary axis by intravenous testosterone in normal women.  Am J Obstet Gynecol . 1986;  155 1288-1292
  • 62 Spinder T, Spijkstra J J, Van Den Tweel. The effect of long term testosterone administration on pulsatile LH secretion and ovarian histology in eugonadal female to male transsexuals.  J Clin Endocrinol Metab . 1989;  69 151-157
  • 63 Pastor C L, Griffin-Korf M L, Aloi J A. Polycystic ovarian syndrome: evidence for reduced sensitivity of the GnRH pulse generator to inhibition by estradiol and progesterone.  J Clin Endocrinol Metab . 1998;  83 582-590
  • 64 Daniels T L, Berga S L. Resistance of GnRH drive to sex steroid induced suppression in hyperandrogenemic anovulation.  J Clin Endocrinol Metab . 1997;  82 4179-4183
  • 65 Eagleson C A, Gingrich M B, Pastor C L. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.  J Clin Endocrinol Metab . 2000;  85 4047-4052
  • 66 Dumesic D A, Abbott D H, Eisner J R, Goy R W. Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood.  Fertil Steril . 1997;  67 155-163
  • 67 Robinson J E, Forsdike R A, Taylor J A. In utero exposure of female lambs to testosterone reduces sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone.  Endocrinology . 1999;  140 5797-5805
  • 68 Venturoli S, Porcu E, Fabri R. Longitudinal evaluation of different gonadotropin pulsatile patterns in anovulatory cycles of young girls.  J Clin Endocrinol Metab . 1992;  74 836-841
  • 69 Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow up of adolescents into the third decade of life.  J Clin Endocrinol Metab . 1990;  71 970-974
  • 70 Venturoli S, Porcu E, Fabbri R. Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities.  Fertil Steril . 1987;  48 78-85
  • 71 Apter D, Butzow T, Laughlin G A. Accelerated 24h LH pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovary syndrome.  J Clin Endocrinol Metab . 1994;  79 119-125
  • 72 Jakacki R I, Kelch R P, Sauder S E. Pulsatile secretion of luteinizing hormone in children.  J Clin Endocrinol Metab . 1982;  55 453-458
  • 73 Marshall J C, Kelch R P. Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction.  N Engl J Med . 1986;  315 1459-1468
  • 74 Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study.  Clin Endocrinol (Oxf) . 1980;  12 107-120
  • 75 Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children.  J Clin Endocrinol Metab . 2000;  85 1074-1080
    >